Bedside blood test may reveal how well heart failure treatment works
NCT ID NCT07762521
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This observational study looks at whether changes in a blood marker called NT-proBNP, measured at the bedside, can reflect how well fluid is being removed in patients hospitalized with acute decompensated heart failure. Participants receive standard care, and researchers track NT-proBNP levels and congestion signs during the first days in the hospital. The goal is to see if this marker could serve as a useful indicator of treatment response, potentially guiding more personalized heart failure management in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Serial NT-proBNP measurement (a blood test measuring a heart stress marker)
- What this could lead to
- If successful, this could show that simple bedside NT-proBNP tests help doctors gauge how well heart failure treatment is working, potentially guiding more personalized care in the future.
- What could go wrong
- This is a small observational study, so it cannot prove cause and effect. The results may not apply to all heart failure patients, and the test is not yet proven to improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE (ADHF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a newer heart failure drug protect kidneys better than an older one?
- ER study: does how you give water pills matter for heart failure?
- Could inflatable leg boots help heart failure patients?
- New heart failure drug trial aims to ease breathing and save lives
- Should heart failure patients stay on jardiance in the hospital? new trial aims to find out
- Heart drug showdown: which works best when kidneys also fail?